| Bid Price | High Price | ||
|---|---|---|---|
| Ask Price | Low Price | ||
| Open Price | Spread | ||
| Prev Close | Volume |
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Feb 19, 2020 | 1,669.80 | 1,688.20 | 1,667.20 | 1,678.00 | 7,139,781 |
| Feb 18, 2020 | 1,651.80 | 1,668.40 | 1,640.40 | 1,667.00 | 17,235,799 |
| Feb 17, 2020 | 1,678.60 | 1,678.60 | 1,658.60 | 1,661.60 | 3,834,192 |
| Feb 14, 2020 | 1,682.20 | 1,683.60 | 1,662.40 | 1,668.60 | 6,640,355 |
| Feb 13, 2020 | 1,692.20 | 1,730.00 | 1,663.20 | 1,681.40 | 8,212,765 |
| Name | Glaxosmithkline | Epic | GSK |
|---|---|---|---|
| ISIN | GB0009252882 | Currency | GBX |
| Type | Equity | Trading Segment | SET1 |
| Record Status | Active | Trading Status | Closed |
| Industry | Health Care | Sector | Pharmaceuticals |
| EMS | 1,000 | Prev Close | 1,678.00 |
| Shares in Issue (m) | 5,016.41 | Market Cap (£m) | 83,623.61 |
| PE Ratio | 17.75 | Div per Share (p) | 80.00 |
| Div Yield | 4.80 | Div Cover | 1.17 |
| EPS | 93.90 | EPS Growth (%) | 27.41 |
| PEG | 0.65 | DPS Growth (%) | 0.00 |
| ROCE | 11.18 | Net Gearing | 71.06 |
| Quick Ratio | 0.56 | Current Ratio | 0.81 |
| Date | Broker | Recomm. | Price | Old Target | New Target | Notes |
|---|---|---|---|---|---|---|
| 20 Feb | Barclays Capital | Underweight | 1,655.00 | 1,550.00 | - | Reiterates |
| 18 Feb | Liberum Capital | Hold | 1,655.00 | 1,930.00 | 1,840.00 | Reiterates |
| 17 Feb | Citigroup | Neutral | 1,655.00 | 1,840.00 | - | Reiterates |
| 13 Feb | Societe Generale | Buy | 1,655.00 | 2,300.00 | 2,240.00 | Retains |
| 13 Feb | HSBC | Buy | 1,655.00 | 2,110.00 | 2,050.00 | Reiterates |
| Date | Director | Type | Volume / Price | Trade Value |
|---|---|---|---|---|
| 20 Feb 2020 | Emma Walmsley | Exercise | 62,036 @ 0p | £0.00 |
| 20 Feb 2020 | Emma Walmsley | Sale Post-Exercise | 29,203 @ 1,661.4p | £485,178.64 |
| 06 Feb 2020 | Jonathan Symonds | Buy | 11,730 @ 1,705.000p | £199,996.50 |
| 05 Feb 2020 | Urs Rohner | Buy | 399 @ 1,800.000p | £7,182.00 |
| 05 Feb 2020 | Manvinder Banga | In Lieu of Fees/Salary | 399 @ 1,800.000p | £7,182.00 |
You can opt out at any time.
